Japan’s First Committee On Drugs Approves 11 Drugs Including Two SGLT2 Inhibitors
This article was originally published in PharmAsia News
Executive Summary
Japan PAFSC First Committee on Drugs approved 11 new drugs, including two new SGLT-2 inhibitors for type 2 diabetes treatment.